Co-Authors
This is a "connection" page, showing publications co-authored by SANJIV HARPAVAT and MARY BRANDT.
Connection Strength
0.673
-
Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements. JAMA. 2020 03 24; 323(12):1141-1150.
Score: 0.179
-
A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy. Contemp Clin Trials Commun. 2019 Sep; 15:100370.
Score: 0.168
-
Factors Influencing Time-to-diagnosis of Biliary Atresia. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):850-856.
Score: 0.158
-
Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia. J Pediatr Gastroenterol Nutr. 2016 06; 62(6):799-803.
Score: 0.137
-
Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver transplant. World J Gastroenterol. 2014 Aug 28; 20(32):11062-8.
Score: 0.030